⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3447972 | 1.00 | — | — | |
| SCHEMBL2971356 | 0.78 | — | — | |
| SCHEMBL2971353 | 0.78 | — | — | |
| SCHEMBL31607321 | 0.69 | CES1 (0.44) | — | |
| SCHEMBL18573862 | 0.67 | CES2 (0.32) | — | |
| SCHEMBL4989271 | 0.67 | CES1 (0.45) | — | |
| SCHEMBL2102369 | 0.65 | — | — | |
| SCHEMBL2102367 | 0.65 | — | — | |
| SCHEMBL27848848 | 0.65 | — | — | |
| SCHEMBL3841640 | 0.65 | HDAC3 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8796324-B2 | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-08-05 | — | — | US | disclosed |
| US-20120238607-A1 | SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-09-20 | — | — | US | disclosed |
| US-8202895-B2 | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-06-19 | — | — | US | disclosed |
| US-20100261771-A1 | SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-10-14 | — | — | US | disclosed |
| US-20100029985-A1 | Process | AVECIA PHARMACEUTICALS LIMITED (GB) | 2010-02-04 | — | — | US | disclosed |
| WO-2009037497-A1 | PROCESS FOR PREPARING SULPHONAMIDES | NPIL PHARMACEUTICALS (UK) LIMITED (GB) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009037416-A1 | PROCESS FOR PREPARING SULPHONAMIDES | NPIL PHARMACEUTICALS (UK) LIMITED (GB) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009019412-A1 | RACEMISATION PROCESS FOR OBTAINING (1S,4S) N-METHYL-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENEAMINE (SERTRALINE) | NPIL PHARMACEUTICALS (UK) LIMITED (GB) | 2009-02-12 | — | — | WO | disclosed |
| US-7462731-B2 | Processes for the preparation of heterocyclic hydroxyamines and intermediates and catalysts for use therein | NPIL PHARMACEUTICALS (UK) LIMITED (GB) | 2008-12-09 | — | — | US | disclosed |
| US-20080223287-A1 | Plasma enhanced ALD process for copper alloy seed layers | LAVOIE ADRIEN R | 2008-09-18 | — | — | US | disclosed |
| EP-1339655-A1 | TRANSFER HYDROGENATION PROCESS AND CATALYST | Avecia Limited (GB) | 2003-09-03 | — | — | EP | disclosed |
| US-6545188-B2 | Catalytic hydrogenation a acetophenone compound or corresponding imine compound | AVECIA LIMITED (GB) | 2003-04-08 | — | — | US | disclosed |
| US-20020156282-A1 | Transfer hydrogenation process and catalyst | AVECIA LIMITED | 2002-10-24 | — | — | US | disclosed |
| EP-0971865-B1 | TRANSFER HYDROGENATION PROCESS AND CATALYST | AVECIA LTD (GB) | 2002-08-14 | — | — | EP | disclosed |
| WO-2002044111-A1 | TRANSFER HYDROGENATION PROCESS AND CATALYST | AVECIA LIMITED (GB) | 2002-06-06 | — | — | WO | disclosed |
| EP-1210305-A1 | TRANSFER HYDROGENATION PROCESS | Avecia Limited (GB) | 2002-06-05 | — | — | EP | disclosed |
| US-6372931-B1 | CATALYST COMPRISING COMPLEX OF TRANSITION METAL, CHELATING LIGAND AND CYCLOPENTADIENYL GROUP | AVECIA LIMITED (GB) | 2002-04-16 | — | — | US | disclosed |
| WO-2001012574-A1 | TRANSFER HYDROGENATION PROCESS | AVECIA LIMITED (GB) | 2001-02-22 | — | — | WO | disclosed |
| EP-0971865-A1 | TRANSFER HYDROGENATION PROCESS AND CATALYST | Avecia Limited (GB) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042643-A1 | TRANSFER HYDROGENATION PROCESS AND CATALYST | AVECIA LIMITED (GB) | 1998-10-01 | — | — | WO | disclosed |